Researchers at the Rosie Maternity Hospital in Cambridge are trialing a pioneering neonatal brain monitoring “swimming cap” that could transform the early diagnosis and care of babies at risk of neurological injury.
The portable cap uses an innovative combination of light based diffuse optical tomography and functional ultrasound to monitor oxygen changes at the brain’s surface, as well as deep-brain blood-flow patterns. Unlike an MRI or traditional cranial ultrasound – which are limited by access, cost, noise and their inability to provide frequent imaging – this cot side device enables repeated monitoring that is minimally disruptive during the critical early weeks when the brain changes rapidly.
Brain injury affects around five in every 1,000 newborns and can lead to long-term conditions, such as cerebral palsy, epilepsy and learning difficulties. Early and precise detection may significantly accelerate interventions, improve developmental outcomes and shorten the diagnostic journey. The cap’s ability to capture brain function continuously and comprehensively represents a major step forward, and if successful, the technology could be introduced into hospitals within the next decade.
For health insurers, this technology could shift costs earlier in life, with increased demand for neonatal monitoring and early therapeutic intervention. However, earlier diagnosis and timely treatment may reduce the severity and long term cost associated with chronic neurological conditions, potentially lowering lifetime claims. Insurers may need to update reimbursement models to account for new diagnostic pathways while also preparing for increased utilization of pediatric therapies as more children are identified earlier.
For life insurers, emerging advances in diagnostic precision early in life may, over time, enhance understanding of long‑term morbidity and mortality risk. While still evolving and subject to uncertainty, this has the potential to inform actuarial assumptions as evidence matures and outcomes become better characterized. At the same time, insurers must navigate ethical considerations around the use of neonatal health data, ensuring fair underwriting and compliance with evolving regulation.
RGA experts are eager to engage with clients to better understand and tackle the industry’s most pressing challenges together. Contact us to learn more about RGA's capabilities, resources, and solutions.
